Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

AQMS vs RCUS vs ALTG vs AGEN

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
AQMS
Aqua Metals, Inc.

Waste Management

IndustrialsNASDAQ • US
Market Cap$17M
5Y Perf.-96.9%
RCUS
Arcus Biosciences, Inc.

Biotechnology

HealthcareNYSE • US
Market Cap$2.50B
5Y Perf.-20.9%
ALTG
Alta Equipment Group Inc.

Rental & Leasing Services

IndustrialsNYSE • US
Market Cap$265M
5Y Perf.+21.7%
AGEN
Agenus Inc.

Biotechnology

HealthcareNASDAQ • US
Market Cap$132M
5Y Perf.-95.0%

AQMS vs RCUS vs ALTG vs AGEN — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
AQMS logoAQMS
RCUS logoRCUS
ALTG logoALTG
AGEN logoAGEN
IndustryWaste ManagementBiotechnologyRental & Leasing ServicesBiotechnology
Market Cap$17M$2.50B$265M$132M
Revenue (TTM)$0.00$236M$1.82B$114M
Net Income (TTM)$-23M$-369M$-79M$115K
Gross Margin90.7%25.7%35.7%
Operating Margin-168.6%0.9%-17.7%
Forward P/E1.8x
Total Debt$592K$99M$1.17B$10M
Cash & Equiv.$11M$222M$19M$3M

AQMS vs RCUS vs ALTG vs AGENLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

AQMS
RCUS
ALTG
AGEN
StockMay 20May 26Return
Aqua Metals, Inc. (AQMS)1003.1-96.9%
Arcus Biosciences, … (RCUS)10079.1-20.9%
Alta Equipment Grou… (ALTG)100121.7+21.7%
Agenus Inc. (AGEN)1005.0-95.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: AQMS vs RCUS vs ALTG vs AGEN

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: RCUS and AGEN are tied at the top with 2 categories each — the right choice depends on your priorities. Agenus Inc. is the stronger pick specifically for growth and revenue expansion and operational efficiency and capital deployment. AQMS and ALTG also each lead in at least one category. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
AQMS
Aqua Metals, Inc.
The Quality Compounder

AQMS is the clearest fit if your priority is quality.

  • 1.2% margin vs RCUS's -156.4%
Best for: quality
RCUS
Arcus Biosciences, Inc.
The Long-Run Compounder

RCUS carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.

  • 45.9% 10Y total return vs ALTG's -8.9%
  • Lower volatility, beta 1.95, Low D/E 15.7%, current ratio 4.36x
  • Beta 1.95, current ratio 4.36x
  • Beta 1.95 vs AGEN's 2.72
Best for: long-term compounding and sleep-well-at-night
ALTG
Alta Equipment Group Inc.
The Income Pick

ALTG is the clearest fit if your priority is dividends.

  • 1.1% yield; the other 3 pay no meaningful dividend
Best for: dividends
AGEN
Agenus Inc.
The Income Pick

AGEN is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.

  • Dividend streak 1 yrs, beta 2.72
  • Rev growth 10.4%, EPS growth 100.0%, 3Y rev CAGR 5.2%
  • 10.4% revenue growth vs RCUS's -4.3%
  • 0.1% ROA vs AQMS's -157.5%
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthAGEN logoAGEN10.4% revenue growth vs RCUS's -4.3%
Quality / MarginsAQMS logoAQMS1.2% margin vs RCUS's -156.4%
Stability / SafetyRCUS logoRCUSBeta 1.95 vs AGEN's 2.72
DividendsALTG logoALTG1.1% yield; the other 3 pay no meaningful dividend
Momentum (1Y)RCUS logoRCUS+209.6% vs AQMS's -51.5%
Efficiency (ROA)AGEN logoAGEN0.1% ROA vs AQMS's -157.5%

AQMS vs RCUS vs ALTG vs AGEN — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

AQMSAqua Metals, Inc.

Segment breakdown not available.

RCUSArcus Biosciences, Inc.
FY 2025
License And Development Services
87.4%$221M
Development Services
6.7%$17M
R&D Services
3.2%$8M
License
2.8%$7M
ALTGAlta Equipment Group Inc.
FY 2025
Parts Sales
40.0%$291M
Service
35.3%$257M
Rental Revenue
24.7%$180M
AGENAgenus Inc.
FY 2025
Non Cash Royalty Revenue
99.1%$109M
Other
0.9%$1M

AQMS vs RCUS vs ALTG vs AGEN — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLAGENLAGGINGALTG

Income & Cash Flow (Last 12 Months)

AGEN leads this category, winning 3 of 6 comparable metrics.

ALTG and AQMS operate at a comparable scale, with $1.8B and $0 in trailing revenue. AGEN is the more profitable business, keeping 0.1% of every revenue dollar as net income compared to RCUS's -156.4%. On growth, AGEN holds the edge at +27.5% YoY revenue growth, suggesting stronger near-term business momentum.

MetricAQMS logoAQMSAqua Metals, Inc.RCUS logoRCUSArcus Biosciences…ALTG logoALTGAlta Equipment Gr…AGEN logoAGENAgenus Inc.
RevenueTrailing 12 months$0$236M$1.8B$114M
EBITDAEarnings before interest/tax-$22M-$391M$90M-$10M
Net IncomeAfter-tax profit-$23M-$369M-$79M$115,000
Free Cash FlowCash after capex-$11M-$489M$63M-$159M
Gross MarginGross profit ÷ Revenue+90.7%+25.7%+35.7%
Operating MarginEBIT ÷ Revenue-168.6%+0.9%-17.7%
Net MarginNet income ÷ Revenue-156.4%-4.3%+0.1%
FCF MarginFCF ÷ Revenue-2.1%+3.5%-139.1%
Rev. Growth (YoY)Latest quarter vs prior year-39.3%-3.0%+27.5%
EPS Growth (YoY)Latest quarter vs prior year+71.4%+10.5%+4.6%+85.3%
AGEN leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

Evenly matched — AQMS and ALTG and AGEN each lead in 1 of 3 comparable metrics.
MetricAQMS logoAQMSAqua Metals, Inc.RCUS logoRCUSArcus Biosciences…ALTG logoALTGAlta Equipment Gr…AGEN logoAGENAgenus Inc.
Market CapShares × price$17M$2.5B$265M$132M
Enterprise ValueMkt cap + debt − cash$7M$2.4B$1.4B$140M
Trailing P/EPrice ÷ TTM EPS-0.34x-7.54x-3.20x-1102.94x
Forward P/EPrice ÷ next-FY EPS est.1.79x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple27.27x
Price / SalesMarket cap ÷ Revenue10.11x0.14x1.16x
Price / BookPrice ÷ Book value/share0.52x4.22x
Price / FCFMarket cap ÷ FCF7.09x
Evenly matched — AQMS and ALTG and AGEN each lead in 1 of 3 comparable metrics.

Profitability & Efficiency

AGEN leads this category, winning 3 of 9 comparable metrics.

RCUS delivers a -69.0% return on equity — every $100 of shareholder capital generates $-69 in annual profit, vs $-33 for ALTG. AQMS carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to RCUS's 0.16x. On the Piotroski fundamental quality scale (0–9), AGEN scores 6/9 vs RCUS's 0/9, reflecting solid financial health.

MetricAQMS logoAQMSAqua Metals, Inc.RCUS logoRCUSArcus Biosciences…ALTG logoALTGAlta Equipment Gr…AGEN logoAGENAgenus Inc.
ROE (TTM)Return on equity-2.5%-69.0%-32.5%
ROA (TTM)Return on assets-157.5%-35.3%-5.7%+0.1%
ROICReturn on invested capital-166.7%-64.1%+1.4%
ROCEReturn on capital employed-139.5%-42.1%+2.7%
Piotroski ScoreFundamental quality 0–93056
Debt / EquityFinancial leverage0.04x0.16x
Net DebtTotal debt minus cash-$10M-$123M$1.2B$7M
Cash & Equiv.Liquid assets$11M$222M$19M$3M
Total DebtShort + long-term debt$592,000$99M$1.2B$10M
Interest CoverageEBIT ÷ Interest expense-32.95x-13.38x0.38x1.11x
AGEN leads this category, winning 3 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

RCUS leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in RCUS five years ago would be worth $8,143 today (with dividends reinvested), compared to $93 for AQMS. Over the past 12 months, RCUS leads with a +209.6% total return vs AQMS's -51.5%. The 3-year compound annual growth rate (CAGR) favors RCUS at 7.7% vs AQMS's -71.6% — a key indicator of consistent wealth creation.

MetricAQMS logoAQMSAqua Metals, Inc.RCUS logoRCUSArcus Biosciences…ALTG logoALTGAlta Equipment Gr…AGEN logoAGENAgenus Inc.
YTD ReturnYear-to-date-3.6%+6.5%+62.8%+16.1%
1-Year ReturnPast 12 months-51.5%+209.6%+80.5%+27.1%
3-Year ReturnCumulative with dividends-97.7%+24.9%-35.8%-88.2%
5-Year ReturnCumulative with dividends-99.1%-18.6%-33.1%-93.9%
10-Year ReturnCumulative with dividends-99.7%+45.9%-8.9%-94.3%
CAGR (3Y)Annualised 3-year return-71.6%+7.7%-13.8%-51.0%
RCUS leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — RCUS and ALTG each lead in 1 of 2 comparable metrics.

RCUS is the less volatile stock with a 1.95 beta — it tends to amplify market swings less than AGEN's 2.72 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALTG currently trades 90.7% from its 52-week high vs AQMS's 13.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricAQMS logoAQMSAqua Metals, Inc.RCUS logoRCUSArcus Biosciences…ALTG logoALTGAlta Equipment Gr…AGEN logoAGENAgenus Inc.
Beta (5Y)Sensitivity to S&P 5002.26x1.95x2.30x2.72x
52-Week HighHighest price in past year$39.40$28.72$8.99$7.34
52-Week LowLowest price in past year$3.37$7.06$4.16$2.71
% of 52W HighCurrent price vs 52-week peak+13.0%+86.3%+90.7%+51.1%
RSI (14)Momentum oscillator 0–10071.960.569.148.8
Avg Volume (50D)Average daily shares traded43K1.2M212K814K
Evenly matched — RCUS and ALTG each lead in 1 of 2 comparable metrics.

Analyst Outlook

AGEN leads this category, winning 1 of 1 comparable metric.

Analyst consensus: RCUS as "Buy", ALTG as "Buy", AGEN as "Buy". Consensus price targets imply 95.5% upside for AGEN (target: $7) vs 1.2% for ALTG (target: $8). ALTG is the only dividend payer here at 1.12% yield — a key consideration for income-focused portfolios.

MetricAQMS logoAQMSAqua Metals, Inc.RCUS logoRCUSArcus Biosciences…ALTG logoALTGAlta Equipment Gr…AGEN logoAGENAgenus Inc.
Analyst RatingConsensus buy/hold/sellBuyBuyBuy
Price TargetConsensus 12-month target$30.00$8.25$7.33
# AnalystsCovering analysts18511
Dividend YieldAnnual dividend ÷ price+1.1%
Dividend StreakConsecutive years of raises01
Dividend / ShareAnnual DPS$0.09
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%+2.8%+0.1%
AGEN leads this category, winning 1 of 1 comparable metric.
Key Takeaway

AGEN leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). RCUS leads in 1 (Total Returns). 2 tied.

Best OverallAgenus Inc. (AGEN)Leads 3 of 6 categories
Loading custom metrics...

AQMS vs RCUS vs ALTG vs AGEN: Key Questions Answered

9 questions · data-driven answers · updated daily

01

Is AQMS or RCUS or ALTG or AGEN a better buy right now?

For growth investors, Agenus Inc.

(AGEN) is the stronger pick with 10. 4% revenue growth year-over-year, versus -4. 3% for Arcus Biosciences, Inc. (RCUS). Analysts rate Arcus Biosciences, Inc. (RCUS) a "Buy" — based on 18 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — AQMS or RCUS or ALTG or AGEN?

Over the past 5 years, Arcus Biosciences, Inc.

(RCUS) delivered a total return of -18. 6%, compared to -99. 1% for Aqua Metals, Inc. (AQMS). Over 10 years, the gap is even starker: RCUS returned +45. 9% versus AQMS's -99. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — AQMS or RCUS or ALTG or AGEN?

By beta (market sensitivity over 5 years), Arcus Biosciences, Inc.

(RCUS) is the lower-risk stock at 1. 95β versus Agenus Inc. 's 2. 72β — meaning AGEN is approximately 39% more volatile than RCUS relative to the S&P 500. On balance sheet safety, Aqua Metals, Inc. (AQMS) carries a lower debt/equity ratio of 4% versus 16% for Arcus Biosciences, Inc. — giving it more financial flexibility in a downturn.

04

Which is growing faster — AQMS or RCUS or ALTG or AGEN?

By revenue growth (latest reported year), Agenus Inc.

(AGEN) is pulling ahead at 10. 4% versus -4. 3% for Arcus Biosciences, Inc. (RCUS). On earnings-per-share growth, the picture is similar: Agenus Inc. grew EPS 100. 0% year-over-year, compared to -30. 1% for Alta Equipment Group Inc.. Over a 3-year CAGR, RCUS leads at 30. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — AQMS or RCUS or ALTG or AGEN?

Agenus Inc.

(AGEN) is the more profitable company, earning 0. 1% net margin versus -142. 9% for Arcus Biosciences, Inc. — meaning it keeps 0. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALTG leads at 1. 3% versus -156. 3% for RCUS. At the gross margin level — before operating expenses — RCUS leads at 96. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Is AQMS or RCUS or ALTG or AGEN more undervalued right now?

Analyst consensus price targets imply the most upside for AGEN: 95.

5% to $7. 33.

07

Which pays a better dividend — AQMS or RCUS or ALTG or AGEN?

In this comparison, ALTG (1.

1% yield) pays a dividend. AQMS, RCUS, AGEN do not pay a meaningful dividend and should not be held primarily for income.

08

Is AQMS or RCUS or ALTG or AGEN better for a retirement portfolio?

For long-horizon retirement investors, Alta Equipment Group Inc.

(ALTG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (1. 1% yield). Aqua Metals, Inc. (AQMS) carries a higher beta of 2. 26 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ALTG: -8. 9%, AQMS: -99. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between AQMS and RCUS and ALTG and AGEN?

These companies operate in different sectors (AQMS (Industrials) and RCUS (Healthcare) and ALTG (Industrials) and AGEN (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

ALTG pays a dividend while AQMS, RCUS, AGEN do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

AQMS

Quality Business

  • Sector: Industrials
  • Market Cap > $100B
Run This Screen
Stocks Like

RCUS

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 54%
Run This Screen
Stocks Like

ALTG

Stable Dividend Mega-Cap

  • Sector: Industrials
  • Market Cap > $100B
  • Gross Margin > 15%
  • Dividend Yield > 0.5%
Run This Screen
Stocks Like

AGEN

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 13%
  • Gross Margin > 21%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.